Antabio (private company)

See something wrong or missing? Let us know
Offices:Toulouse
Business model:B2B

Antabio is a French developer of treatments for drug-resistant bacterial infections

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 27.02M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Antabio

Name Criteria
Germany Atai Life Sciences
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Sano Genetics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Netherlands Leyden Labs
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mogrify
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Causaly
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Ochre Bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France Xenothera
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom bit.bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Synthace
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top